Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma × Immunotherapy, Adoptive × Clear all

Sponsor

Conditions

Lymphoma, Mantle-Cell 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myeloid, Acute 2 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Burkitt Lymphoma 1 Brain Neoplasms 1

Interventions

Pemetrexed 11 Cisplatin 10 pembrolizumab 7 Carboplatin 6 Ipilimumab 5 Nivolumab 4 durvalumab 3 LMB-100 3 Gemcitabine 3 tremelimumab 2 tazemetostat 2 anetumab ravtansine 2 Vinorelbine 2 Plicamycin 2 Dexamethasone 2 Cyclophosphamide 2 Bevacizumab 2 vandetanib 1 tocilizumab 1 ribociclib 1 rebastinib 1 pevonedistat 1 olaparib 1 niraparib 1 nintedanib 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 defactinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡